A Study of PNT2258 in Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This study is sponsored by Sierra Oncology, Inc. formerly ProNAi Therapeutics, Inc. The
purpose of this research study is to evaluate the safety of the investigational drug PNT2258
in patients with advance tumors and see how it acts in the body.